Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · IEX Real-Time Price · USD
2.150
-0.040 (-1.83%)
At close: Jul 19, 2024, 4:00 PM
2.160
+0.010 (0.47%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Eterna Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1993
Revenue
0.120.0700019.81
Upgrade
Revenue Growth (YoY)
------15.12%
Upgrade
Cost of Revenue
0.250.240007.48
Upgrade
Gross Profit
-0.13-0.1700012.32
Upgrade
Selling, General & Admin
15.3114.5916.8414.723.313.18
Upgrade
Research & Development
5.75.9210.3912.713.950
Upgrade
Other Operating Expenses
0.790.797.1386.300.92
Upgrade
Operating Expenses
21.8121.334.36113.737.2514.09
Upgrade
Operating Income
-21.94-21.47-34.36-113.73-7.25-1.77
Upgrade
Interest Expense / Income
1.40.610.03000.25
Upgrade
Other Expense / Income
-0.44-0.41-9.858.750.04-
Upgrade
Pretax Income
-22.9-21.67-24.53-122.48-7.29-2.02
Upgrade
Income Tax
-0-00.050.0600.03
Upgrade
Net Income
-22.9-21.67-24.58-122.55-7.29-2.05
Upgrade
Preferred Dividends
0.020.020.020.0200.02
Upgrade
Net Income Common
-22.92-21.68-24.6-122.56-7.29-2.06
Upgrade
Shares Outstanding (Basic)
553210
Upgrade
Shares Outstanding (Diluted)
553210
Upgrade
Shares Change
5.52%74.17%40.92%146.19%1123.51%6.96%
Upgrade
EPS (Basic)
-4.25-4.08-8.06-56.61-8.20-28.80
Upgrade
EPS (Diluted)
-4.25-4.08-8.06-56.61-8.20-28.80
Upgrade
Free Cash Flow
-18.22-20.43-21.02-23.64-8.141.65
Upgrade
Free Cash Flow Per Share
-3.37-3.84-6.89-10.92-9.2622.96
Upgrade
Gross Margin
-114.78%-247.06%---62.22%
Upgrade
Operating Margin
-19078.26%-31572.06%----8.94%
Upgrade
Profit Margin
-19926.09%-31888.24%----10.42%
Upgrade
Free Cash Flow Margin
-15845.22%-30039.71%---8.33%
Upgrade
EBITDA
-19.9-19.93-24.01-122.02-7.191.4
Upgrade
EBITDA Margin
-17305.22%-29314.71%---7.05%
Upgrade
Depreciation & Amortization
1.61.120.50.460.13.17
Upgrade
EBIT
-21.5-21.06-24.5-122.48-7.29-1.77
Upgrade
EBIT Margin
-18698.26%-30966.18%----8.94%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).